Provided by Tiger Trade Technology Pte. Ltd.

Agenus

8.33
-1.6000-16.11%
Post-market: 8.420.0869+1.04%18:57 EDT
Volume:1.95M
Turnover:17.57M
Market Cap:375.02M
PE:3.33
High:9.99
Open:9.95
Low:8.28
Close:9.93
52wk High:10.31
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:1.40
T/O Rate:4.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-1.88
PE(LYR):-2,452.89

Loading ...

Agenus Shares Rise After Chardan Initiates Coverage at Buy

MT Newswires Live
·
Sep 29

Agenus Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Sep 28

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 22

Chardan Initiates Agenus at Buy With $40 Price Target

MT Newswires Live
·
Sep 18

Agenus initiated with a Buy at Chardan

TIPRANKS
·
Sep 18

Agenus Director Marco Tullio Marcucci Files Initial Beneficial Ownership Statement

Reuters
·
Sep 16

Agenus files to sell 221,525 shares of common stock for holders

TIPRANKS
·
Sep 12

Agenus to Present 3-Year Survival Data for Botensilimab-Balstilimab Ovarian Cancer Study at IGCS 2026

Reuters
·
Sep 10

Agenus Releases Corporate Overview Presentation on Botensilimab-Balstilimab Neoadjuvant Colon Cancer Data

Reuters
·
Sep 03

Agenus Joins Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 31

Agenus Reports 21.2-Month Median Survival in Phase 1b Bot+bal Study for MSS Metastatic Colorectal Cancer

Reuters
·
Aug 28

Agenus: No colorectal cancer recurrences observed at updated follow-up in trial

TIPRANKS
·
Aug 26

Agenus Reports no Recurrences in Phase 2 NEST Trial of Botensilimab Plus Balstilimab in Resectable Colon Cancer

Reuters
·
Aug 26

Agenus Posts Investor Deck Spotlighting Botensilimab-Balstilimab Neoadjuvant Program in MSS Colon Cancer

Reuters
·
Aug 21

Agenus Modifies Loan and Issues Unregistered Equity

TIPRANKS
·
Aug 19

Agenus - Unit Enters Second Loan Modification Agreement with Ocean 1181 on Aug 12, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus - Loan Principal $24.75 Mln, Maturity Extended to Nov 30, 2029, Interest 13.0% Per Annum - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus Extends $24.75 Million Loan Maturity to Nov. 2029 in Ocean 1181 Amendment

Reuters
·
Aug 19

Agenus Grants CEO Garo Armen 1,971,500 Performance-Based Stock Options at $7.78 Per Share

Reuters
·
Aug 13

Agenus Strengthens Board With New Director Appointment

TIPRANKS
·
Aug 12